A new mole-map service will launch in pharmacies this week to
make life-saving melanoma diagnosis more accessible to New
Zealanders.
MoleMap Spot Checks will be launched at selected pharmacies
to increase public uptake of skin lesion diagnosis.
Skin cancer is the most common form of cancer in New Zealand,
affecting around 45,000 Kiwis every year, with about 320
dying from the disease annually.
MoleMap CEO Adrian Bowling says the service - being piloted
at Life Pharmacy St Lukes, Glenfield and Albany - will make
lesion diagnosis both more affordable and convenient.
"Often people notice changes in a mole but may put off doing
something until it's too late. Now it's something they can
get checked out in the mall during their lunch hour, without
the need for an appointment," Mr Bowling said.
Auckland dermatologist and MoleMap medical director Dr Mark
Gray said it's important that New Zealanders and their
partners take more notice of lesions on their skin and
particularly those that fall into the "ugly duckling"
category.
This category is used by skin cancer researchers to explain
the theory that moles on individuals generally tend to
resemble one another, and the ones that don't are of higher
concern, he says.
Dr Gray says when one mole seems to fall outside of the norm
it is worth having a medical professional take a closer look
at it.
Images of the lesions will be taken with the latest MoleMap
custom-designed melanoma camera.
It will then be sent by a secure link to a panel of
MoleMap-registered dermatologists along with a patient
history and details for review.
Patients can then expect a diagnosis report within a few
days.
A name, residential address, and (preferably residential) telephone number is required from readers who comment on ODT Online. These details will not be visible to site visitors.